ALFA — AlphaClone Alternative Alpha ETF
Data updated: 2022-08-29
ALFA — AlphaClone Alternative Alpha ETF. Money Market · $21.02M AUM · 0.65% expense ratio · -37.8% 1-yr return. Holdings, fees, performance and SEC filings.
ALFA Fund Overview
ALFA — AlphaClone Alternative Alpha ETF is a US ETF managed by ETF Series Solutions, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: ETF Series Solutions
- Category: Money Market
- Assets under management: $21.02M
- 1-year return: -37.8%
- Ticker: ALFA
- SEC CIK: 0001540305
- SEC series ID: S000036971
- Share class ID: C000113128
ALFA Investment Objective and Strategy
AlphaClone Alternative Alpha ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by ETF Series Solutions.
Investment objective
The AlphaClone Alternative Alpha ETF (the Fund) seeks to track the price and yield, before fees and expenses, of the AlphaClone Hedge Fund Masters Index (the Index).
Principal investment strategy
The Fund uses a passive management (or indexing) approach to track the performance, before fees and expenses, of the Index. AlphaClone Hedge Fund Masters Index The Index utilizes a proprietary, quantitative Clone Score methodology developed by AlphaClone, Inc. (AlphaClone), the Funds index provider, to replicate the U.S. equity securities favored as investments by hedge funds and institutional investors. The Index was established by AlphaClone in 2017 and is composed of up to 50 U.S.-listed equity securities of small, mid, or large capitalization companies and reconstituted quarterly. AlphaClones Clone Score methodology analyzes the historical returns of a given hedge funds or institutional investors holdings and assigns a Clone Score (i.e., ranking) to each such hedge fund and institutional investor based on such returns.
Clone Scores are recalculated semi-annually. The Clone Score methodology incorporates information from hedge fund and institutional investor public disclosure filings (e.g., Form 13F filings) with the U.S. Securities and Exchange Commission to identify their disclosed holdings at the end of each quarter. The Index is made up of the equity securities held by those hedge funds and institutional investors with the highest Clone Scores. Index constituents are equal weighted at the time of each reconstitution, although each individual constituent is limited to a 5% weighting at the time of each reconstitution. The equity securities that may comprise the Index include, but are not limited to, U.S.-listed common and preferred stock of domestic and foreign companies, including those in emerging markets, real estate investment trusts (REITs), master limited partnerships (MLPs), and American Depositary Receipts (ADRs).
Such securities may be issued by small, mid, or large capitalization companies and must meet certain liquidity thresholds at the time of reconstitution to be included in the Index. The Funds Investment Strategy The Fund attempts to invest all, or substantially all, of its assets in the component securities that make up the Index. Under normal circumstances, at least 80% of the Funds total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the Index. The Fund expects that, over time, the correlation between the Funds performance and that of the Index, before fees and expenses, will be 95% or better. The Fund will generally use a replication strategy to achieve its investment objective, meaning the Fund generally will invest in all of the component securities of the Index in approximately the same proportion as in the Index.
However, the Fund may use a representative sampling strategy, meaning it may invest in a sample of the securities in the Index whose risk, return and other characteristics closely resemble the risk, return and other characteristics of the Index as a whole, when the Funds sub-adviser believes it is in the best interests of the Fund ( e.g. , when replicating the Index involves practical difficulties or substantial costs, an Index constituent becomes temporarily illiquid, unavailable or less liquid, or as a result of legal restrictions or limitations that apply to the Fund but not to the Index). The Fund generally may invest up to 20% of its total assets (exclusive of any collateral held from securities lending) in securities or other investments not included in the Index, but which the Funds sub-adviser believes will help the Fund track the Index.
For example, the Fund may invest in securities that are not components of the Index to reflect various corporate actions and other changes to the Index (such as reconstitutions, additions and deletions). On a day-to-day basis, the Fund also may hold money market mutual funds or short-term debt instruments that have terms-to-maturity of less than 397 days and exhibit high quality credit profiles, including U.S. government securities and repurchase agreements. To the extent the Index concentrates (i.e., holds more than 25% of its total assets) in the securities of a particular industry or group of related industries, the Fund will concentrate its investments to approximately the same extent as the Index. As of March 31, 2018, securities in the consumer, financial, health care, industrial, and information technology sectors represented a significant portion of the Index.
ALFA Performance
Total returns for ALFA (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | -37.8% |
| 3 years (annualised) | -4.1% |
ALFA Risk Information
Risk metrics for ALFA, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 23.0%
ALFA Costs and Fees
ALFA costs about $65 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.65%
- Gross expense ratio: 0.65%
- Portfolio turnover: 207%
- Brokerage commissions: 6.95 bps of average net assets (SEC N-CEN)
ALFA Cashflows
Over the 12 months to 2022-06, AlphaClone Alternative Alpha ETF had net inflows of $74.83M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2022-06 | $0 |
| 2022-05 | $7.51M |
| 2022-04 | $0 |
| 2022-03 | $1.77M |
| 2022-02 | $16.69M |
| 2022-01 | $0 |
ALFA Debt Constituents
No individual debt constituents are reported in AlphaClone Alternative Alpha ETF's latest SEC N-PORT filing.
ALFA Prospectus and SEC Filings
Official AlphaClone Alternative Alpha ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2022-07-26
- Prospectus (485BPOS) — filed 2021-07-20
- Prospectus (485BPOS) — filed 2020-07-22
- Portfolio holdings (N-PORT) — filed 2022-08-29
- Portfolio holdings (N-PORT) — filed 2022-05-27
- Portfolio holdings (N-PORT) — filed 2022-02-28
- Annual census (N-CEN) — filed 2022-06-13
- Annual census (N-CEN) — filed 2021-06-14
Related Funds
Other Money Market funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.